Stories

Since March 2020, the COVID-19 pandemic has had a lasting impact on the lives of millions of people around the world, including the many brave health care workers who risked their own health to provide lifesaving care to those infected by the virus. That care was made possible, in part, by the lasting impact that the pandemic has also had on laboratory testing.

This week's Research Roundup features: Performance comparisons of methylation and structural variants from low-input whole-genome methylation sequencing.

Before joining Mayo Clinic, Samantha Aldrich worked for a multisite hospital system in Michigan for 10 years. Now, as a regional service representative for Mayo Clinic Laboratories, she serves as a client advocate and works to help send out laboratories improve their operations, services, education, and training.

This week's Research Roundup features: Novel through-the-scope suture closure of colonic Endoscopic Mucosal resection defects.

This week's Research Roundup features: Membranous nephropathy in syphilis is associated with neuron-derived neurotrophic factor.

As someone affected by chronic liver disease, Susan Parrott knows how it feels to live in uncertainty. But every few months, the anxiety and doubt that shadow her life fade when Mayo Clinic Laboratories test results confirm her condition is in check and she can continue living life on her own terms.

Today's Highlights Include: COVID-19 deaths remain low compared to previous winters, FDA authorizing first at-home combo flu/Covid test, and Rochester public schools evaluating mental health needs and services throughout the district.

As a senior principal developer for the brand-new Process Innovation Through Automation Laboratory, Brian Dukek helps labs throughout the Department of Laboratory Medicine and Pathology evaluate new automation tools and streamline automation workflows.

This week's Research Roundup features: Laboratory and metabolic investigations.

Today's Highlights Include: Ozempic running low for diabetes patients as weight-loss use surges, and Rochester public schools gets $1.9M for mental health scholarships.

As a director of operations for Mayo Clinic Laboratories, Callie Bishop helps meet the needs of Mayo Clinic Laboratories clients both virtually and onsite in the field.

Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all four have been shown to respond to immunotherapy.

After what looked like a blemish turned out to be angiosarcoma, a rare, life-threatening cancer of the blood vessels, Alison O'Neill was put on an aggressive treatment plan and regenerative approach to healing made possible by the pathologist who first diagnosed her cancer.